ANAPTYSBIO, INC. Capital Expenditures Incurred but Not yet Paid
ANAPTYSBIO, INC. (ANAB) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-KT filed 2026-09-21.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-09-21
- ANAPTYSBIO, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$23.00K.
- ANAPTYSBIO, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $23.00K, a 109.09% increase year-over-year.
- ANAPTYSBIO, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ANAPTYSBIO, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $11.00K.
- ANAPTYSBIO, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- ANAPTYSBIO, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $7.00K, a 12.50% decline from fiscal 2023.
- ANAPTYSBIO, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $8.00K, a 94.81% decline from fiscal 2022.
- ANAPTYSBIO, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $154.00K, a 396.77% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$23.00K derived: 10-KT 6 month − 10-Q 3 month · filed 2026-09-21 | $0.00 10-KT · filed 2026-09-21 | $0.00 derived: sum of 3 quarters · filed 2026-09-21 | |
| 2026-03-31 | $23.00K 10-Q · filed 2026-05-12 | $23.00K derived: sum of 2 quarters · filed 2026-09-21 | ||
| 2025-12-31 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2026-09-21 | $0.00 10-KT · filed 2026-09-21 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 | |||
| 2025-03-31 | $11.00K 10-Q · filed 2026-05-12 | $14.00K derived: sum of 2 quarters · filed 2026-09-21 | $18.00K derived: sum of 3 quarters · filed 2026-09-21 | $18.00K derived: sum of 4 quarters · filed 2026-09-21 |
| 2024-12-31 | $3.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2026-09-21 | $7.00K derived: sum of 2 quarters · filed 2026-09-21 | $7.00K derived: sum of 3 quarters · filed 2026-09-21 | $7.00K 10-KT · filed 2026-09-21 |
| 2024-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.00K derived: sum of 2 quarters · filed 2025-11-04 | $4.00K 10-Q · filed 2025-11-04 | -$267.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $0.00 10-Q · filed 2024-08-05 | -$271.00K derived: sum of 3 quarters · filed 2026-03-03 | -$44.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-05 | -$271.00K derived: sum of 2 quarters · filed 2026-03-03 | -$44.00K derived: sum of 3 quarters · filed 2026-03-03 | -$30.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | -$271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$44.00K derived: sum of 2 quarters · filed 2026-03-03 | -$30.00K derived: sum of 3 quarters · filed 2026-03-03 | $8.00K 10-K · filed 2026-03-03 |
| 2023-09-30 | $227.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $241.00K derived: sum of 2 quarters · filed 2024-11-05 | $279.00K 10-Q · filed 2024-11-05 | $405.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $52.00K 10-Q · filed 2024-08-05 | $178.00K derived: sum of 3 quarters · filed 2025-02-27 | $206.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $38.00K 10-Q · filed 2024-05-09 | $164.00K derived: sum of 2 quarters · filed 2025-02-27 | $192.00K derived: sum of 3 quarters · filed 2025-02-27 | $173.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $154.00K derived: sum of 2 quarters · filed 2025-02-27 | $135.00K derived: sum of 3 quarters · filed 2025-02-27 | $154.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $9.00K derived: sum of 2 quarters · filed 2023-11-02 | $28.00K 10-Q · filed 2023-11-02 | $48.00K derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | $20.00K derived: sum of 3 quarters · filed 2024-03-11 | -$58.00K derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | $19.00K 10-Q · filed 2023-05-11 | $39.00K derived: sum of 2 quarters · filed 2024-03-11 | -$39.00K derived: sum of 3 quarters · filed 2024-03-11 | -$8.00K derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$58.00K derived: sum of 2 quarters · filed 2024-03-11 | -$27.00K derived: sum of 3 quarters · filed 2024-03-11 | $31.00K 10-K · filed 2024-03-11 |
| 2021-09-30 | -$78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$47.00K derived: sum of 2 quarters · filed 2022-11-08 | $11.00K 10-Q · filed 2022-11-08 | $125.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $89.00K 10-Q · filed 2022-08-08 | $203.00K derived: sum of 3 quarters · filed 2023-03-01 | $343.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $58.00K 10-Q · filed 2022-05-04 | $172.00K derived: sum of 2 quarters · filed 2023-03-01 | $312.00K derived: sum of 3 quarters · filed 2023-03-01 | $251.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $254.00K derived: sum of 2 quarters · filed 2023-03-01 | $193.00K derived: sum of 3 quarters · filed 2023-03-01 | $279.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $79.00K derived: sum of 2 quarters · filed 2021-11-04 | $165.00K 10-Q · filed 2021-11-04 | $124.00K derived: sum of 4 quarters · filed 2022-03-07 |
| 2020-06-30 | -$61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $25.00K 10-Q · filed 2021-08-09 | -$16.00K derived: sum of 3 quarters · filed 2022-03-07 | $52.00K derived: sum of 4 quarters · filed 2022-03-07 |
| 2020-03-31 | $86.00K 10-Q · filed 2021-05-04 | $45.00K derived: sum of 2 quarters · filed 2022-03-07 | $113.00K derived: sum of 3 quarters · filed 2022-03-07 | -$106.00K derived: sum of 4 quarters · filed 2022-03-07 |
| 2019-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $27.00K derived: sum of 2 quarters · filed 2022-03-07 | -$192.00K derived: sum of 3 quarters · filed 2022-03-07 | $41.00K 10-K · filed 2022-03-07 |
| 2019-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$151.00K derived: sum of 2 quarters · filed 2020-11-04 | $82.00K 10-Q · filed 2020-11-04 | $81.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$219.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $14.00K 10-Q · filed 2020-08-10 | $13.00K derived: sum of 3 quarters · filed 2021-02-25 | -$21.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $233.00K 10-Q · filed 2020-05-06 | $232.00K derived: sum of 2 quarters · filed 2021-02-25 | $198.00K derived: sum of 3 quarters · filed 2021-02-25 | $385.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$35.00K derived: sum of 2 quarters · filed 2021-02-25 | $152.00K derived: sum of 3 quarters · filed 2021-02-25 | $159.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $153.00K derived: sum of 2 quarters · filed 2019-11-08 | $160.00K 10-Q · filed 2019-11-08 | $339.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $194.00K 10-Q · filed 2019-08-08 | $373.00K derived: sum of 3 quarters · filed 2020-03-02 | $376.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $7.00K 10-Q · filed 2019-05-07 | $186.00K derived: sum of 2 quarters · filed 2020-03-02 | $189.00K derived: sum of 3 quarters · filed 2020-03-02 | $146.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $182.00K derived: sum of 2 quarters · filed 2020-03-02 | $139.00K derived: sum of 3 quarters · filed 2020-03-02 | $191.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$40.00K derived: sum of 2 quarters · filed 2018-11-08 | $12.00K 10-Q · filed 2018-11-08 | $116.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $9.00K 10-Q · filed 2018-08-07 | $113.00K derived: sum of 3 quarters · filed 2019-02-28 | $113.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $52.00K 10-Q · filed 2018-05-08 | $156.00K derived: sum of 2 quarters · filed 2019-02-28 | $156.00K derived: sum of 3 quarters · filed 2019-02-28 | $149.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $104.00K derived: sum of 2 quarters · filed 2019-02-28 | $97.00K derived: sum of 3 quarters · filed 2019-02-28 | $104.00K 10-K · filed 2019-02-28 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$7.00K derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | |
| 2016-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $0.00 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | $7.00K 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | $11.00K 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |